Rothschild Investment »

Candel Therapeutics shares owned by Rothschild Investment

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2026-03-31 $15 3 5.00

More positions owned by Rothschild Investment

Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Invesco Rafi Us 1000 Etf Etf (PRF)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Amazon Stock (AMZN)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Exxon Mobil Corp Stock (XOM)
Johnson & Johnson Stock (JNJ)
Capital Group Dividend Growers Etf Etf (CGDG)
Blackstone Stock (BX)
Abbvie Stock (ABBV)
Chevron Corporation Stock (CVX)

View all positions for Rothschild Investment

Top funds holding Candel Therapeutics

FMR
BlackRock
Portolan Capital Management
Acorn Capital Advisors
Vanguard Capital Management
Vanguard Group
Vestal Point Capital
Millennium Management
Geode Capital Management
Halter Ferguson Financial
State Street Corporation
Sands Capital Ventures
Northern Trust
Vanguard Fiduciary Trust
Vanguard Portfolio Management

View all funds holding Candel Therapeutics